Answers are grounded in this paper and cite their sources.
Some recent advances in the search for tumor‐specific immunity in man are reviewed. The development of new techniques for the in vitro detection of tumor‐induced immune reactions has led to the discovery of both cell‐mediated and humoral immunity induced by a variety of human tumors. Malignant melanomas, Burkitt's lymphomas, neuroblastomas, and choriocarcinomas rank high on the list of antigenic tumors and are associated with a better than average prognosis. Immunotherapy based on the antigenic differences between normal and tumor cells is briefly discussed.
No takes yet. Share an insight, caveat, or question.
Willy F. Piessens (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: